bf/NASDAQ:SONN_icon.jpeg

COM:SONNETBIO

Sonnet BioTherapeutics Holdings, Inc.

  • Stock

USD

Last Close

2.89

22/11 21:00

Market Cap

2.61M

Beta: -

Volume Today

45.44K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
Sep '24
asset turnover
0.87
-
1.00
-
1.25
23.97%
1.37
10.23%
1.02K
74,323.41%
0.02
-
0.06
259.85%
0.03
54.65%
0.01
75.31%
cash conversion cycle
26.49
-
19.30
27.16%
16.48
14.62%
-59.31
459.98%
-8.67K
-
cash per share
0.10
-
0.11
-
0.01
88.46%
0.11
773.28%
0.09
13.67%
10.92
11,603.59%
15.75
44.23%
0.70
95.54%
2.19
212.00%
0.23
89.59%
company equity multiplier
1.79
-
1.94
-
2.67
37.39%
2.82
5.78%
-0.01
100.50%
2.65
19,048.16%
1.30
50.80%
-2.30
276.31%
-24.03
946.24%
-5.70
76.26%
days of inventory outstanding
18.90
-
14.71
22.17%
12.28
16.48%
22.01
79.18%
days of payables outstanding
84.79
-
10.61K
-
days of sales outstanding
4.74
-
7.60
-
4.59
39.56%
4.19
8.66%
3.48
17.00%
1.94K
-
dividend yield
ebit per revenue
-0.33
-
-0.27
-
-0.06
76.81%
-0.13
101.13%
-0.12
8.25%
-51.87
-
-84.78
63.44%
-127.14
49.96%
-636.18
400.36%
ebt per ebit
1.03
-
1.25
-
1.58
26.99%
1.49
5.76%
1.03
30.65%
1.00
3.23%
1.00
0.52%
1.00
0.59%
1.00
0.04%
0.63
37.37%
effective tax rate
0.01
-
0.05
265.35%
-0.08
272.43%
-0.03
59.47%
-0.28
737.58%
-0.00
99.69%
-0.00
100.29%
-0.00
20.52%
1
47,091.28%
enterprise value multiple
-323.90K
-
-84.95K
-
-78.63K
7.44%
-8.23K
89.53%
-467.85
94.32%
-49.89
89.34%
-12.09
75.76%
-4.65
61.51%
-0.05
98.95%
-0.37
656.66%
fixed asset turnover
3.11
-
2.55
-
3.62
42.17%
4.85
33.82%
3.88
19.95%
2.65
-
1.16
56.45%
0.65
43.67%
0.13
80.12%
free cash flow per share
-0.50
-
-0.93
-
-12.09
1,199.12%
-23.32
92.87%
-12.86
44.83%
-6.57
48.90%
-20.98
219.21%
-13.14
37.40%
gross profit margin
1
-
0.67
-
0.68
1.48%
0.67
1.38%
0.80
20.19%
1
-
1
0%
0.49
51.25%
1
105.13%
interest coverage
3.31
-
1.12
66.28%
2.02
80.88%
1.86
7.74%
-1.17K
63,024.90%
727.64
-
inventory turnover
19.32
-
24.82
28.49%
29.72
19.73%
16.59
44.19%
long term debt to capitalization
0.05
-
0.05
-
0.24
399.08%
0.02
91.90%
19.42
99,777.27%
0.08
99.61%
0.00
98.20%
-0.09
6,459.44%
-1.38
1,475.31%
-0.11
92.29%
net income per ebt
1
-
0.85
-
2.19
158.24%
0.87
60.25%
1.03
18.79%
1.28
23.86%
1.00
21.81%
1.00
0.09%
1
0.18%
1
0%
net profit margin
-0.34
-
-0.29
-
-0.22
23.97%
-0.16
24.65%
-0.12
24.42%
-51.71
-
-85.08
64.55%
-127.42
49.75%
-399.29
213.38%
operating cash flow per share
-0.38
-
-0.29
-
-5.83
1,930.76%
-23.21
298.29%
-12.86
44.57%
-6.37
50.49%
-20.56
222.84%
-13.14
36.10%
operating cycle
26.49
-
19.30
27.16%
16.48
14.62%
25.49
54.70%
1.94K
-
operating profit margin
-0.33
-
-0.27
-
-0.06
76.81%
-0.13
101.13%
-0.12
8.25%
-51.87
-
-84.78
63.44%
-127.14
49.96%
-636.18
400.36%
payables turnover
4.30
-
0.03
-
pretax profit margin
-0.34
-
-0.34
-
-0.10
70.56%
-0.19
89.54%
-0.12
36.38%
-51.66
-
-84.93
64.41%
-127.42
50.02%
-399.29
213.38%
price fair value
167.03K
-
52.43K
-
58.08K
10.76%
4.97K
91.45%
-774.07
115.58%
176.37
122.79%
14.80
91.61%
-55.39
474.28%
-13.19
76.20%
-9.02
31.56%
receivables turnover
77.02
-
48.05
-
79.51
65.46%
87.05
9.48%
104.88
20.49%
0.19
-
return on assets
-0.30
-
-0.29
-
-0.27
5.74%
-0.23
16.95%
-126.63
56,150.64%
-3.89
96.93%
-0.86
77.80%
-5.11
492.15%
-3.47
32.08%
-2.68
22.62%
return on capital employed
-0.40
-
-0.44
-
-0.12
72.23%
-0.34
179.60%
1.65
582.84%
-7.41
547.96%
-1.13
84.82%
12.71
1,229.07%
197.57
1,454.79%
26.98
86.34%
return on equity
-0.53
-
-0.56
-
-0.72
29.50%
-0.63
12.15%
1.77
378.76%
-10.29
681.37%
-1.12
89.08%
11.73
1,144.01%
83.34
610.58%
15.31
81.63%
total debt to capitalization
0.11
-
0.30
-
0.45
48.92%
0.46
1.89%
8.65
1,799.57%
0.10
98.79%
0.01
94.63%
-0.11
2,094.25%
-9.24
8,139.35%
-0.37
96.01%

All numbers in USD (except ratios and percentages)